Great, so Glück needs to get on the phone and sel

Great, so Glück needs to get on the phone and sell Regeneron or Celgene on Leronlimab. That's his job now. Pfizer is trying to take over NASH, they presented, then withdrew, Ervogastat/Clesacostat Combination for NASH at the last conference. Our job is to convince them that LL is the answer.